Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 12/11/02 → 11/30/05 |
Financiación
- GlaxoSmithKline: 34.679,00 US$
A Phase II Trial of Twice Daily Oral Topotecan as a Radiation Sensitizer with Twice Daily Radiotherapy for Newly Diagnosed Small Cell Lung Cancer
- Arnold, Susanne M (PI)